DekaBank Deutsche Girozentrale
BRLI

DekaBank Deutsche Girozentrale’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-36,600
Closed -$1.51M – 1231
2015
Q2 		$1.51M Buy
36,600
+7,900
+28% +$283K 0.02% 496
2015
Q1 		$1.01M Buy
+28,700
New +$971K 0.01% 572
2014
Q2 		– Sell
-3,200
Closed -$89K – 1002
2014
Q1 		$89K Buy
+3,200
New +$83.7K ﹤0.01% 804

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BRLI Position: Q3 2015 in Review

DekaBank Deutsche Girozentrale sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 36,600 shares — an estimated $1.51M sold.

DekaBank Deutsche Girozentrale first reported a position in BRLI in Q1 2014 and held it in 3 quarters. The position peaked at $1.51M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • DekaBank Deutsche Girozentrale reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 36,600 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.51M.
  • DekaBank Deutsche Girozentrale first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 3 quarters.
  • DekaBank Deutsche Girozentrale's BIO-REFERENCE LABS INC-NEW- position peaked at $1.51M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2015, filed 6 Nov 2015.